期刊文献+

糖尿病肾病患者血清Ⅳ型胶原、层粘连蛋白水平变化及干预治疗观察 被引量:2

The changes of the serum of the type Ⅳ collagen and Laminin in diabetic nephropathies and the effect of interfered treatment
原文传递
导出
摘要 目的探讨血清Ⅳ型胶原(ⅣC)、层粘连蛋白(LN)与糖尿病肾病(DN)的相关性及血管紧张素转换酶抑制剂(ACEI)干预治疗对其影响。方法选择2型糖尿病(DM)患者166例及正常对照(NC)55例,根据尿白蛋白排泄率(UAER),将2型DM患者分为正常蛋白尿组(NA)、微量蛋白尿组(MA)、临床蛋白尿组(ODN),分别检测各组的血清ⅣC、LN,并观察干预治疗后上述指标的变化。结果2型DM患者血清ⅣC、LN水平高于NC组(P<001),DM患者从NA组、MA组到ODN组,血清ⅣC、LN逐渐增高,各组间差异有显著意义(P<001)。MA组和ODN组经干预治疗后,血清ⅣC、LN水平较前有显著性降低,UAER较前有显著性下降。结论血清ⅣC、LN水平变化与DN的发生发展密切相关,早期应用ACEI有助于防止或延缓DN的病理学进展。 Objective To investigate the relationship between diabetic nephropathy(DN),the serum level of type Ⅳ collagen(Ⅳ-C) and laminin(LN).The effect of interfered treatment of ACEI to DN was also studied.Methods As well as 55 healthy people were collected as the control group,166 cases of type-2 diabetes were collected as DM group and were divided into three groups according to the urinary albumin excretion rate(UAER).They are normal-album-urea(NA) group,micro-album-urea(MA) group and overt-diabetic-nephropathy(ODN) group.The serum level of Ⅳ-C & LN after and before interfered treatment of each case were detected and analyzed.Results The serum level of Ⅳ-C & LN of DM group was much higher than that of the control group(P<0.01).The level of Ⅳ-C & LN of ODN group was higher than that of the MA group,and that of the MA group was higher than that of the NA group,and the differences were significant(P<0.01).After the treatment of ACEI,the serum level of Ⅳ-C,LN and UAER of MA & ODN groups was significantly lower than that of before treatment.Conclusions The changes of serum level of Ⅳ-C & LN were closely correlated with DN.The application of ACEI in the early stage is helpful to prevent/postpone the progress of DN.
出处 《中国基层医药》 CAS 2005年第2期133-134,共2页 Chinese Journal of Primary Medicine and Pharmacy
基金 惠州市医学科学技术研究项目(惠市科字[2001]第8号)
关键词 Ⅳ-C LN 患者 干预治疗 血清Ⅳ型胶原 DM DN 水平 结论 显著性 Diabetic nephropathy Collagen Laminin
  • 相关文献

参考文献3

  • 1Koya D,Jirousek MR, Lin YW,et al. Characteriation of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extra cellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest, 1997,100( 1 ): 115.
  • 2李慎军,张忠辉.糖尿病肾病基底膜成分的改变[J].国外医学(内分泌学分册),2000,20(3):132-135. 被引量:23
  • 3Okazaki R. Matsuoka K, Atsumi Y. Serum concentration of bascment membrane proteins in NIDDM as a prognostic marker for nephropathy. Diabetes Res Clin Pract, 1995,27( 1 ) :39.

二级参考文献14

  • 1Meryer J, Szukies B,Neubauer k, etal. Extracellular matrix proteins as a early markers in diabetic nephropathy 〔J〕. EurJ Clin Chem Clin Biochem, 1995,33:211~215.
  • 2Kreisbery JI, Radmile RA, Ayosh J, et al. High glucose elevates c-fos and c-juntranscripts and proteins in mesangial cell cultures 〔J〕. kidney Int, 1994,45:105~112.
  • 3Eiji Ⅰ, Yoshilci N, shigeichj S. Serum type Ⅲ、Ⅳ collagens and TIMP inpatient with type 2 diabetes mellitus 〔J〕. life Sci, 1996,58:1331~1337.
  • 4Banu U, Hara H, Okarnura M, et al. Urinary excretion of type Ⅳ collagen andlaminin in the evaluation of nephropathy in NIDDM: comparision with urinary albumin andmarkers of tubular dysfunction and/or damage 〔J〕. Diabetes Res Clin Pract, 1995,29:57~67.
  • 5Meyer Ⅱ, Szukics B, Neubauer k, et al. Extracellullar matrix proteins as earlymarkers in diabetic nephropathy 〔J〕. Eur J Clin Chem Clin Biochem, 1995,33:211~219.
  • 6Takahashi M, Dohi N, Nishioka H. Increased urinary fibronectin excertion in typeⅡ diabetie patients with microalbuminuria 〔J〕. Nippon Jinzo Gakkai Shi, 1995,37:336~342.
  • 7Kanauchi M, Nishioka H, Dohi N. Diagnostic significance of urinary fibronectin indiabetic nephropathy 〔J〕. Nippon Jinzo Gakkei Shi, 1995,37:127~133.
  • 8Pichup JC, Mattoch MB, Chusney GD. NIDDM as a disease of the innate immune system:association of acute-phase reactants and interleukin-6 with metabolic syndrome 〔J〕.Diabetologia, 1997,40:1286~1292.
  • 9Pichup TC, Roberts GA, Kehely AM, et al. Higher serum sialic acid in women than inmen with NIDDM: Possible relevance to increased cardiovascular in NIDDM women 〔J〕.Diabetes Care, 1997,20:1496~1507.
  • 10Chen J, Gall MA, Yokoyama H. Raised serum sialic acid concentration in NIDDMpatients with and without diabetic nephropathy 〔J〕. Diabetes Care, 1996,19:130~134.

共引文献22

同被引文献17

  • 1Marshall SM. Recent advances in diabetic nephropathy[J]. Postgraduate Medical Journal, 2004,80 (949) : 624-33.
  • 2Witch WE. Insights into the abnormalities of chronic renal disease attributed to malnutrition[J]. J Am Soc Nephrol, 2002, 13( Suppl 1) :S22-27.
  • 3Doyonnas R, Kershaw DB, Duhme C, et al. Anuria, omphalocele,and perinatal lethality in mice lacking the CD34- related protein podocatyxin [J]. J Exp. Med, 2001,194(1) : 13- 27.
  • 4Asanuma K, Mundel P. The role of podocytes in glomerular pathobiology[J]. Clin Exp Nephrol, 2003,7 (4) : 255-259.
  • 5Matsumae T, Jimi S, Uesugi N, et al. Clinical and morphometrieal interrelationships in patients with overt nephropathy induced by non-insulin dependent diabetes mellitus:a light- and electron-microscopy study [J]. Nephron, 1999,81(1) :41-48.
  • 6Hayashi H,Karasawa R, Inn H, et al. An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus[J]. Kidney Int, 1992,41 (4): 749- 757.
  • 7Goode NP, Shires M, Crellin DM, et al. Alterations of glomerular basement membrane charge and structure in diabetic nephropathy [J]. Diabetologia, 1995, 38 ( 12 ) : 1455- 1465.
  • 8Kikkawa R, Togawa M, Isono M, et al. Mechanism of the progression of diabetic nephropathy to renal failure[J]. Kidney Int, 1997,52 (Suppl 62): S39-40.
  • 9National Kidney Foundation. Kidney Disease Outcome Quality Initiative. K/DOQI clinical practice guidelines for chronic kidneydisease:evaluation, classification, andstratification [J].AmJ Kidney Dis, 2002, 39(2 Suppl 2) S1-246
  • 10Laping NJ. Hepatocyte growth factor: a regulator of extracellular matrix genes in mouse mesangial cells[J].Biochem Pharmacol, 2000, 59:847

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部